February 11, 2020

Women In Bio Names Selexis Director of Business Development and Licensing Jessica Bosc as President

Read More
January 29, 2020

Meet with Selexis Scientific and Business Leaders at Upcoming Industry Conferences

Read More
January 09, 2020

Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer

Read More
October 17, 2019

Teneobio and Selexis Expand Relationship with Three Commercial License Agreements for Multi-specific Antibody Candidates in Oncology

Read More
September 17, 2019

Generium Launches First Biosimilar of Dornase Alfa; Becomes Sixth Approved Product Using Selexis SUREtechnology Platform

Read More